Abstract
Dendritic cells are crucial in determining the functional outcome of allergen encounter in the lung. Antigen presentation by myeloid DCs leads to Th2 sensitization typical of allergic disease, whereas antigen presentation by plasmacytoid DCs serves to dampen inflammation. It is increasingly clear that DCs have an antigen presenting function beyond sensitisation. DCs therefore constitute a novel target for the development of anti-allergic therapy aimed at the origin of the inflammatory cascade. A careful study of DC biology and of the receptors expressed by lung DCs has provided a framework for the discovery of novel anti-allergic compounds.
Keywords: Dendritic Cells, Allergic Disease, immune system, Th2 cells, dampen inflammation, anti-allergic therapy, Drug Targets, Airway inflammation
Current Molecular Medicine
Title: Lung Dendritic Cells: Targets for Therapy in Allergic Disease
Volume: 8 Issue: 5
Author(s): Bart N. Lambrecht
Affiliation:
Keywords: Dendritic Cells, Allergic Disease, immune system, Th2 cells, dampen inflammation, anti-allergic therapy, Drug Targets, Airway inflammation
Abstract: Dendritic cells are crucial in determining the functional outcome of allergen encounter in the lung. Antigen presentation by myeloid DCs leads to Th2 sensitization typical of allergic disease, whereas antigen presentation by plasmacytoid DCs serves to dampen inflammation. It is increasingly clear that DCs have an antigen presenting function beyond sensitisation. DCs therefore constitute a novel target for the development of anti-allergic therapy aimed at the origin of the inflammatory cascade. A careful study of DC biology and of the receptors expressed by lung DCs has provided a framework for the discovery of novel anti-allergic compounds.
Export Options
About this article
Cite this article as:
Lambrecht N. Bart, Lung Dendritic Cells: Targets for Therapy in Allergic Disease, Current Molecular Medicine 2008; 8 (5) . https://dx.doi.org/10.2174/156652408785160916
DOI https://dx.doi.org/10.2174/156652408785160916 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Targeting Microglial Activation in Stroke Therapy: Pharmacological Tools and Gender Effects
Current Medicinal Chemistry Editorial (Thematic Issue: Current Update on Association Between Alzheimer’s Disease and Type 2 Diabetes: Volume I)
CNS & Neurological Disorders - Drug Targets The Impact of Antiplatelet Treatment on Endothelial Function
Current Pharmaceutical Design Encouraging microRNA-based Therapeutic Strategies for Hepatocellular Carcinoma
Anti-Cancer Agents in Medicinal Chemistry Critical Issues for Successful Immunotherapy in Alzheimers Disease: Development of Biomarkers and Methods for Early Detection and Intervention
CNS & Neurological Disorders - Drug Targets Current Advances in Retroviral Gene Therapy
Current Gene Therapy Sauropus androgynus Leaves for Health Benefits: Hype and the Science
The Natural Products Journal Towards More Successful Gene Therapy Clinical Trials for β-Thalassemia
Current Molecular Medicine Unraveling Progesterone-Induced Molecular Mechanisms in Physiological and Pathological Conditions
Current Clinical Pharmacology Systemic Involvement of IgG4-related Sclerosing Disease
Current Immunology Reviews (Discontinued) Protein Engineering for Improved Health: Technological Perspectives
Current Protein & Peptide Science The Impact of the Emerging Genomics Data on the Management of Agerelated Phenotypes in the Context of Cellular Senescence
Current Drug Targets Use of Cytokines in Cancer Vaccines/Immunotherapy: Recent Developments Improve Survival Rates for Patients with Metastatic Malignancy
Current Pharmaceutical Design O-methylation of Hydroxyl-containing Organic Substrates: A Comprehensive Overview
Current Organic Chemistry Erlotinib: A Targeted Anticancer Drug
Current Cancer Therapy Reviews Withdrawal Notice: A Panoramic View on the Phytochemical, Nutritional and Therapeutic value of Ziziphus mauritiana Lam.: A Comprehensive Review
Mini-Reviews in Medicinal Chemistry Comparison of the Expression and Immunogenicity of Wild-Type and Sequence-Modified HIV-1 gag Genes in a Recombinant Sendai Virus Vector
Current HIV Research Patent Selections
Recent Patents on Biotechnology Bioactive Peptides from Marine Sources as Potential Anti-Inflammatory Therapeutics
Current Protein & Peptide Science Mechanisms Involved in the Development of Chronic Hepatitis C as Potential Targets of Antiviral Therapy
Current Pharmaceutical Biotechnology